Method of providing aripiprazole to patients having impaired CYP2D6 or CYP3A4 enzyme function | Patent Publication Number 20200360370

US 20200360370 A1

Patent NumberUS 10980803 B2

Application Number16710495

Filled DateDec 11, 2019

Priority DateSep 24, 2013

Publication DateNov 19, 2020

Original AssigneeOtsuka Holdings Co. Ltd.

Current AssigneeOtsuka Holdings Co. Ltd.

Inventor/ApplicantsArash Raoufinia

Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Check our Latest Report Purchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.